This article has Open Peer Review reports available.
Quantification of resting myocardial blood flow velocity in normal humans using real-time contrast echocardiography. A feasibility study
© Malm et al; licensee BioMed Central Ltd. 2005
Received: 30 April 2005
Accepted: 16 June 2005
Published: 16 June 2005
Real-time myocardial contrast echocardiography (MCE) is a novel method for assessing myocardial perfusion. The aim of this study was to evaluate the feasibility of a very low-power real-time MCE for quantification of regional resting myocardial blood flow (MBF) velocity in normal human myocardium.
Twenty study subjects with normal left ventricular (LV) wall motion and normal coronary arteries, underwent low-power real-time MCE based on color-coded pulse inversion Doppler. Standard apical LV views were acquired during constant IV. infusion of SonoVue®. Following transient microbubble destruction, the contrast replenishment rate (β), reflecting MBF velocity, was derived by plotting signal intensity vs. time and fitting data to the exponential function; y (t) =A (1-e-β(t-t0)) + C.
Low-power real-time MCE did have the potential to give contrast enhancement for quantification of resting regional MBF velocity. However, the technique is difficult and subjected to several limitations. Significant variability in β suggests that this parameter is best suited for with-in patient changes, comparing values of stress studies to baseline.
MCE is an emerging technique for non-invasive evaluation of myocardial perfusion and coronary heart disease (CAD) [1–11]. Recent advances in multipulse technology have made real-time MCE feasible with low acoustic power [12–17], giving minimal contrast destruction and frame rates that facilitate evaluation of scan plane and wall motion. However, technical difficulties concerning tailored ultrasound equipment, imaging techniques, data-analysis and interpretation still remain to be solved.
The majority of MCE studies have reported data relying on visual assessment somewhat limited by its subjective approach . Wei and coworkers pioneered a method for more objective quantification of MBF with contrast microbubbles administered as constant intravenous infusion . From the time course of video intensity during progressively prolonged pulsing intervals, both MBF velocity and myocardial blood volume (MBV) could be assessed. The product of these two parameters was shown to correlate well with radiolabeled microsphere-derived MBF [5, 17, 19, 20]. This quantitative approach has also been applied to real-time MCE techniques [14–16, 19]. A strong linear correlation between the rate of signal intensity (SI) rise and volumetric flow has been reported, both at rest and during hyperemia [14, 16, 22]. On the other hand, steady state SI has not been found to correlate as well with flow measurements [14, 17], indicating that the microbubble replenishment rate might be the major MCE perfusion parameter.
The quantification of replenishment rates is often limited to selected myocardial regions due to imaging problems [19, 22]. To our knowledge there are limited human studies reporting resting replenishment rates for all standard myocardial segments measured in different cardiac phases. The aim of this study was 1) to evaluate the feasibility of a very low-power real-time MCE technique for visualising the perfusion in normal human myocardium, and 2) to quantify the MBF velocity, β, of all myocardial segments of the apical scan views by using the destruction-replenishment approach.
Twenty study subjects were enrolled; ten healthy male volunteers (age 24 ± 3) and ten patients (age 55 ± 5), five of them female. The study subjects were not screened for echocardiographic image quality, the only inclusion criteria being an age above 18 and confirmed normal left ventricular regional and global systolic function by conventional echocardiography. The ten patients had undergone coronary angiography due to chest pain, with the findings of open and normal coronary arteries and normal left ventricular end-diastolic pressures. The healthy volunteers were assumed to have normal coronary anatomy and myocardial perfusion, due to the abscence of CAD risk factors and symptoms, and normal findings on standard echocardiography. All the subjects were in sinus rhythm. Exclusion criteria were pregnancy or lactation, known allergy to the contrast agent, significant valve diseases or shunts, severe pulmonary hypertension, and severe extra-cardiac disease. All the subjects gave their written informed consent to the participation. The study conformed to the declaration of Helsinki, and the Regional Commitee of Medical Ethics approved the protocol.
The ultrasound contrast agent SonoVue® (Bracco, Milan, Italy) was used, consisting of microspheres of sulphur hexafluoride gas (SF6) stabilised by a phospholipid monolayer in an aqueous solution. SonoVue® was infused continuously by a manually rotated volume pump through a 20G vial in a proximal forearm vein. There were slight individual changes of the infusion rate (70–100 ml/ hour) to optimize the myocardial opacification and minimize the far-field attenuation. Once steady state was reached and the recording started, the infusion rate was held constant in every individual study.
Imaging was performed with Vivid 7™ (GE Vingmed Ultrasound, Horten, Norway) with a M3S matrix array transducer. The contrast-specific application, Coded Harmonic Angio™, is a very low power, real-time technique based on pulse inversion combined with power Doppler, operating at a frame rate of 20 Hz. With this choice of application and contrast agent, the optimal agent-tissue-ratio was achieved with a mechanical index (MI) as low as 0.04–0.05. The signal amplitudes were color-coded by the Angio mode and displayed as overlays on fundamental tissue grey-scale images. The focus was set basally, close to the mitral valve plane. The depth was set to let the left ventricle fill the image sector, and color gain was adjusted to reduce the signal-to-noise ratio to the point that hardly any noise was observed within tissue and cavity. The time gain compensation was adjusted to obtain homogenous SI and to reduce the noise from the myocardium, the epi-/ pericardium and the mitral valves. After the initial adjustments all settings were held constant in every individual study.
Baseline imaging was acquired in tissue harmonic mode for confirmation of normal anatomy and wall motion. MCE was performed in the apical four-chamber, two-chamber and long-axis views. Standard views were at times slightly modified, i.e. by centralising the lateral or anterior walls in the scan sector, to optimize the contrast detection and avoid attenuation and shadowing. When the myocardial contrast opacification reached a steady state, a 'flash' of 15 frames of high MI (1.0), timed to cover at least the entire systole, was applied for transient microbubble destruction. This was followed by immediate, automatic return to low MI continuous imaging of microbubble replenishment in end-expiration (See Additional file: 1 Movie demonstrating a real-time destruction-replenishment loop of the LV apical long-axis view). The procedure was repeated twice for every scan view. Fifteen cardiac cycles of every destruction-replenishment sequence, at least 10 after 'flash', were captured and stored digitally as raw-data.
The MCE data were analysed off-line on a PC workstation. Analyses of the cineloops were performed blinded in random order using EchoPAC PC™ (GE Vingmed Ultrasound, Horten, Norway). Measurement of mean signal intensity (dB) was done in manually placed, equally sized and shaped regions of interest (ROI) in the 16 standard myocardial segments , plus the two apical segments of the apical long-axis view. The ROIs were large, avoiding high intensity signals from the cavity and the epi-and endocardium. When necessary, their position was slightly adjusted to compensate for the translation of the heart. The depth of the ROI position was not changed. Finally, all ROIs were 'anchored' for each frame.
The myocardial SI was plotted against time (t) and fitted to the exponential function: y (t) =A (1-e -β(t-t0) ) + C, where y is SI at any time during the contrast replenishment, A is the plateau SI corresponding to MBV, β is the rate of SI rise reflecting the mean bubble velocity or MBF velocity, and C is the intercept at the origin reflecting the background intensity level . The introduction of t 0 simply reflects that the analysis software allowed one to choose where to set t = 0. To further compensate for a possible non-zero initial value after flash, the constant C was added, implicating that the curve fitting was relatively independent of background myocardial SI. The ROIs were positioned and anchored before the curve fitting was applied. Segmental values of A and β were derived from the replenishment cycles by careful frame-by-frame analysis. Separate quantitative analysis was performed both for all-frames, for selected end-systolic (end of T-waves) and end-diastolic (close to peak R-wave) frames.
Continuous variables are presented as mean ± 1SD. Comparison between groups was performed with linear regression analysis (ANOVA), a posthoc analysis was done using Bonferroni's correction. Differences were considered statistically significant at p less than 0.05 (two-sided) with a power of 0.80.
Feasibility of quantitative analysis
Absolute values of segmental myocardial contrast replenishment rate, (s-1)
All frames analysis
0.41 ± 0.11
0.63 ± 0.14
0.56 ± 0.17
0.36 ± 0.12
0.46 ± 0.15
0.47 ± 0.16
0.33 ± 0.14
0.43 ± 0.14
0.42 ± 0.18
0.29 ± 0.10
0.43 ± 0.18
0.30 ± 0.12
0.27 ± 0.11
0.44 ± 0.18
0.37 ± 0.12
0.32 ± 0.13
0.55 ± 0.12
0.37 ± 0.14
0.43 ± 0.17
0.59 ± 0.19
0.44 ± 0.12
0.36 ± 0.09
0.54 ± 0.11
0.46 ± 0.15
0.35 ± 0.10
0.43 ± 0.14
0.34 ± 0.15
0.34 ± 0.10
0.45 ± 0.15
0.60 ± 0.29
0.27 ± 0.18
0.31 ± 0.18
0.21 ± 0.15
0.24 ± 0.21
0.39 ± 0.11
0.35 ± 0.22
0.42 ± 0.14
0.69 ± 0.12
0.61 ± 0.17
0.36 ± 0.15
0.52 ± 0.16
0.40 ± 0.18
0.31 ± 0.13
0.42 ± 0.18
0.44 ± 0.16
0.31 ± 0.11
0.48 ± 0.23
0.33 ± 0.15
0.36 ± 0.15
0.41 ± 0.19
0.47 ± 0.11
0.45 ± 0.19
0.58 ± 0.20
0.48 ± 0.16
Evaluated on a territorial level, perfusion in the LAD area could be assessed in all 20 subjects. Segments usually assigned to the RCA could be evaluated in 15 subjects, whereas the LCx supply area was analysable in only half of the subjects.
By using the software's capability to perform an off-line ECG triggering, we did separate analysis from end-systolic and end-diastolic images (Figure 3). Significantly higher β-values were obtained when end-diastolic frames were analysed compared to end-systolic ones (0.49 ± 0.16 s-1 and 0.35 ± 0.13 s-1 respectively, p < 0.001). The β-values from all-frames analysis were lying between (0.43 ± 0.17 s-1), significantly different from both end-systolic and end-diastolic values (p = 0.002 and p = 0.001, respectively). Approximately the same level of differences was found between cardiac phases for A-values.
There were no significant differences in mean end-systolic β between four-chamber, two-chamber and long-axis views (0.34 ± 0.12 vs 0.35 ± 0.15 vs. 0.36 ± 0.14 s-1, respectively) nor between healthy volunteers and patients (0.36 ± 0.14 vs. 0.35 ± 0.13 s-1).
Hemodynamic and safety parameters
There were no significant changes in the study subjects' blood pressure, heart rate or rythm during performance of the MCE examinations. Each subject received a total dose of 9.5 ml of SonoVue®, and none of them experienced any adverse effect in the observation period, nor were any observed.
Despite recent advances in contrast-specific imaging, our study demonstrates some of the difficulties with and the still limited ability of low-power real-time MCE for quantitative assessment of regional myocardial perfusion. The contrast detection was better in the segments with good precontrast myocardial image quality, the lateral and anterior walls being the poorest with frequent dropouts. The MCE imaging problems were reduced, but not eliminated by adjustment of infusion rates and by carefully repositioning the wall of interest more centrally in the scan sector. Nevertheless, two thirds of segments were feasible for quantitative analysis, and by assigning segments to the coronary territories, the LAD and RCA areas could potentially be evaluated. On the other hand, limited contrast detection made assessment of the LCx area difficult in more than half of the subjects.
Our study was not designed to test specific machine settings or examination variables. Nevertheless, we observed decreasing A values moving distally and laterally in the scan sector. β was similarly found to be lower in lateral than more axial parts, but in opposite to A it significantly increased at greater depths of the sector. This is in accordance with results from in vitro flow phantom and animal models [14, 16], but has previously not been reported in human studies.
The exact mechanism for this spatial variability is uncertain. Variations in beam elevation and non-uniformity of the sound field are probably contributing factors [6, 24, 25]. With a phased array transducer, the acoustic energy delivered is lower laterally than in the centre of the sector, due to smaller effective aperture and some directivity of the elements . Consequently, the backscatter from the microbubbles is inhomogenous. In addition attenuation and other artefacts decreasing backscatter are often more pronounced in the lateral regions. Non-uniformity of the effective regional 'flash' energy level might lead to variable bubble destruction, possibly altering the refilling parameters as well.
Far field attentuation likely contributed to the lowering of A in basal parts of sector. The finding of higher β in basal compared to apical segments could be due to the narrower beam elevation in the focal zone (which was set close to the mitral valve plane), resulting in a thinner scan plane with myocardial contrast destruction, and thereby faster replenishment of contrast from adjacent areas not affected by destruction.
The contrast refilling measurements were also influenced by the selection of frames from the cardiac cycle. We assessed significantly higher β-values from end-diastolic compared to end-systolic measurements. Corresponding values from all-frames analysis were lying in-between. Even the first diastolic frames after the 'flash' displayed some contrast signals, while the earliest systolic frame did not. This might be due to early bubble refilling through larger intramyocardial arterioles that are patent in diastole, but collapsed during systolic contraction [27, 28]. By applying ROIs of uniform shape and size, the risk of capturing strong signals from the pericardium and the cavity seems to be greater in diastole, when the myocardium is thinner and localized more laterally in sector. Assessment of end-systolic frames seems preferable, despite more coronary flow in diastole, because the myocardium is thicker with less risk of 'contamination' from contrast in the blood pool.
These findings are in accordance with results from experimental studies [14, 16]. Leong-Poi et al also found that MBF derived from images obtained in end-systole accurately reflected radiolabeled microsphere-derived MBF, whereas the correlation was poor, with significant overestimation of MBF, when the end-diastolic ones were used .
Insufficient contrast detection with too low agent-to-tissue signal ratio still remains a basic problem in quantifying the perfusion by pulse inversion Doppler. One disadvantage of the low-power real-time mode compared to destructive intermittent imaging, is the weaker backscatter from the non-destructive microbubble behaviour. A larger amount of contrast agent is required, which must be balanced against the degree of far field attenuation. Furthemore, some tissue harmonics are always present, and the movement artefacts will probably not be completely removed by the addition of power Doppler.
Relatively low temporal resolution was another anticipated problem. However, in our experience the applied frame rate of 20 Hz gave sufficient image quality to allow anatomical orientation and wall motion assessment.
An advantage of real-time MCE is the very short data aquisition time. Information that would require approximately a minute with intermittent imaging was recorded during seconds, making it possible to obtain all refill frames during one breathhold. The mean contrast infusion time of 6 minutes allowed us to aquire several replenishment loops from each scan view in every subject. But despite short data acquisition time, the procedure is still demanding. Given a beam elevation of only 3–4 mm at focus, it is mandatory to maintain a stable probe position during the entire destruction-replenishment period. Of the same reson, it is important to put an effort in avoiding off-axis views, particularly whenever tilting the scanplane to centralize a wall for improving contrast detection. Out-of plane imaging would possibly contribute to increased variability of the segmental quantitative parameters. Furtermore, the patients must be cooperative and able to hold their breath for up to ten seconds, preferably in end-expiration, to avoid lung interference and cardiac translation. Even some of our young, healthy study subjects experienced difficulties in this regard.
The sample size of this study was small, and the patients were selected from baseline image quality. The coronary anatomy was not known in all study subjects, and we did not use other methods to ensure normal perfusion in our patients. However, due to the selection criteria it is highly unlikely that subclinical CAD could explain our results.
The main limitation of this study is that we did not apply any manipulations to change blood flow, i.e. adding of vasodilator to obtain maximal hyperaemia. Regional resting perfusion is normally variable, both between segments and study subjects, and this variability is further reinforced by imaging and technical problems with the applied destruction-replenishment approach. In the presence of a non-critical coronary stenosis, normal resting blood flow is maintained by arteriolar vasodilation. And patients with critical lesions often have collateral circulation, making assessment of resting perfusion complex. Hence, the interpretation of replenishment kinetics is particularly difficult at rest. Since normal perfusion is expected to increase at least 3-fold during hyperaemia, giving faster contrast replenishment after transient destruction, the evaluation of stress-to-rest ratios (the MBF velocity reserve) would be a more appropriate quantitative approach to assess normal or abnormal perfusion.
Interestingly, a simplified algorithm using qualitative evaluation of MBF velocity (actually time to complete myocardial opacification after destruction) from a single stress MCE perfusion study, was recently shown to detect CAD in patients with normal left ventricular function at rest, avoiding the need for resting MCE studies . However, in that study triggered imaging was used, and it still seems to be a challenge maintaining a stable probe position for good image alignment during stress studies.
Our study indicated that a very low-power real-time MCE could provide contrast opacification in multiple myocardial segments of the LV apical views. However, the acquistion of flash-replenishment loops adequate for quantification is limited by imaging and technical problems. The interpretation of regional resting replenishment curves is in addition complicated by great variability in normal perfusion. Our data support previous findings in experimental studies, which established that the absolute values of MBF velocity are highly influenced by ultrasound field geometry and which cardiac phase to be analyzed. The MBF velocity need to be interpreted with regard to the imaging technique used and the segments from which they are obtained, and due to the great variability is is probably best applied by analysis of relative changes, that is comparing values during stress with baseline.
Dr. Siri Malm was supported by a Research Fellowship grant from the Norwegian Council for Cardiovascular Diseases. The autors are grateful to Bracco International providing the contrast agent used in this study. We also thank GE Vingmed Ultrasound, Norway, for providing the research ultrasound machine and software. No other financial payments have been made to the project leader or associates, and no obligations to or other connection with the sponsors exists.
- Skyba DM, Jayaweera AR, Goodman NC, Ismail S, Camarano G, Kaul S: Quantification of myocardial perfusion with myocardial contrast echocardiography during left atrial injection of contrast. Implications for venous injection. Circulation 1994, 90: 1513-1521.View ArticlePubMedGoogle Scholar
- Porter TR, Li S, Kiltzer K, Deligonul U: Correlation between quantitative angiographic lesion severity and myocardial contrast intensity during a continuous infusion of perfluorocarbon-containing microbubbles. J Am Soc Echocardiogr 1998, 11: 702-710.View ArticlePubMedGoogle Scholar
- Kaul S, Senior R, Dittrich H, Raval U, Khattar F, Lahiri A: Detection of coronary artery disease with myocardial contrast echocardiography: Comparison with 99mTc-Sestamibi single-photon emission computed tomography. Circulation 1997, 96: 785-792.View ArticlePubMedGoogle Scholar
- Marwick TH, Brunken R, Meland N, Brochet E, Baer FM, Binder T, Flachskampf F, Kamp O, Nienaber C, Nihoyannopoulos P, Pierard L, Vanoverschelde JL, van der Wouw P, Lindwall K, the Nycomed NC100100 Investigators: Accuracy and feasibility of contrast echocardiography for detection of perfusion defects in routine practice: comparison with wall motion and technetium-99m sestamibi single-photon emission computed tomography. J Am Coll Cardiol 1998, 32: 1260-1269. 10.1016/S0735-1097(98)00373-8View ArticlePubMedGoogle Scholar
- Wei K, Jayaweera AR, Firoozan S, Linka A, Skyba DM, Kaul S: Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998, 97: 473-483.View ArticlePubMedGoogle Scholar
- Senior R, Kaul S, Soman P, Lahiri A: Power Doppler contrast echocardiography: a new technique for assessing myocardial perfusion. Am Heart J 2000, 139: 245-251.View ArticlePubMedGoogle Scholar
- Villanueva FS, Gertz EW, Csikari M, Pulido G, Fisher D, Sklenar J: Detection of coronary artery stenosis with power Doppler imaging. Circulation 2001, 103: 2624-2630.View ArticlePubMedGoogle Scholar
- Leistad E, Ohmori K, Peterson A, Christensen G, DeMaria AN: Quantitative assessment of myocardial perfusion during graded coronary artery stenoses by intravenous myocardial contrast echocardiography. J Am Coll Cardiol 2001, 37: 624-31. 10.1016/S0735-1097(00)01127-XView ArticlePubMedGoogle Scholar
- Wei K: Detection and quantification of coronary stenosis severity with myocardial contrast echocardiography. Prog Cardiovasc Dis 2001, 44: 81-100. 10.1053/pcad.2001.26444View ArticlePubMedGoogle Scholar
- Heinle S, Noblin J, Goree-Best P, Mello A, Ravad G, Mull S, Mammen P, Graybrun PA: Assessment of myocardial perfusion by Harmonic Power Doppler Imaging at rest and during adenosine stress. Comparison with 99m Tc-Sestamibi SPECT Imaging. Circulation 2000, 102: 55-60.View ArticlePubMedGoogle Scholar
- Wei K, Crouse L, Weiss J, Villanueva F, Schiller NB, Naqvi T, Siegel R, Monaghan M, Goldman J, Aggarwal P, Feigenbaum H, DeMaria A: Comparison of usefulness of dipyridamol stress myocardial contrast echocardiography to Technetium-99m sestamibi single-photon emission computed tomography for detection of coronary artery disease (PB127 Multicenter Phase 2 Trial Results). Am J Cardiol 2003, 91: 1293-1298. 10.1016/S0002-9149(03)00316-3View ArticlePubMedGoogle Scholar
- Porter TR, Xie F, Silver M, Kricsfeld D, Oleary E: Real-time perfusion imaging with low mechanical index pulse inversion Doppler imaging. J Am Coll Cardiol 2001, 37: 748-753. 10.1016/S0735-1097(00)01204-3View ArticlePubMedGoogle Scholar
- Tiemann K, Lohmeier S, Kuntz S, Köster J, Pohl C, Burns P: Real-time contrast echo assessment of myocardial perfusion at low emission power: First experimental and clinical results using power pulse inversion imaging. Echocardiography 1999, 16: 799-809.View ArticlePubMedGoogle Scholar
- Lafitte S, Masugata H, Peters B, Togni M, Strachan M, Yao B, Kwan OL, DeMaria AN: Accuracy and reproducibility of coronary flow rate assessment by real-rime contrast echocardiography: In vitro and in vivo studies. J Am Soc Echocardiogr 2001, 14: 1010-1019. 10.1067/mje.2001.112908View ArticlePubMedGoogle Scholar
- Masugata H, Peters B, Lafitte S, Strachan GM, Ohmori K, DeMaria AN: Quantitative assessment of myocardial perfusion during graded coronary stenosis by real-time myocardial contrast echo refilling curves. J Am Coll Cardiol 2001, 37: 262-269. 10.1016/S0735-1097(00)01046-9View ArticlePubMedGoogle Scholar
- Leong-Poi H, Le E, Rim SJ, Sakuma T, Kaul S, Wei K: Quantification of myocardial perfusion and determination of coronary stenosis severity during hyperemia using real-time myocardial contrast echocardiography. J Am Soc Echocardiogr 2001, 14: 1173-1182. 10.1067/mje.2001.115982View ArticlePubMedGoogle Scholar
- Masugata H, Peters B, Lafitte S, Strachan GM, Kohno M, DeMaria : Comparison of microbubble agents that produce different myocardial signal intensity for quantification of myocardial blood flow by myocardial contrast echo. Am J Cardiol 2001, 88: 714-718. 10.1016/S0002-9149(01)01828-8View ArticlePubMedGoogle Scholar
- Von Bibra H, Bone D, Niklasson U, Eurenius L, Hansen A: Myocardial contrast echocardiography yields best accuracy using quantitative analysis of digital data from pulse inversion technique: Comparison with second harmonic imaging and harmonic power Doppler during simultaneous Dipyridamol stress SPECT studies. Eur J Echocardiography 2002, 3: 271-282. 10.1053/euje.2002.0166Google Scholar
- Murthy TH, Li P, Locvicchio E, Baisch C, Dairywala I, Armstrong WF, Vannan M: Real-time myocardial blood flow imaging in normal human beings with the use of myocardial contrast echocardiography. J Am Soc Echocardiogr 2001, 14: 698-705. 10.1067/mje.2001.111156View ArticlePubMedGoogle Scholar
- Köster J, Schlosser T, Pohl C, Lentz C, Lohmeier S, Veltman C: Blood flow assessment by ultrasound-induced destruction of echocontrast agents using harmonic power Doppler imaging: which parameters determine contrast replenishment curves? Echocardiography 2001, 18: 1-8. 10.1046/j.1540-8175.2001.00001.xView ArticlePubMedGoogle Scholar
- Masugata H, Lafitte S, Peters B, Strachan GM, DeMaria AN: Comparison of real-time and intermittent triggered myocardial contrast echocardiography for quantification of coronary stenosis severity and transmural perfusion gradient. Circulation 2001, 104: 1550-1556.View ArticlePubMedGoogle Scholar
- Wei K, Ragosta M, Thorpe J, Coggins M, Moos S, Kaul S: Noninvasive quantification of coronary blood flow reserve in humans using myocardial contrast echocardiography. Circulation 2001, 103: 2560-2565.View ArticlePubMedGoogle Scholar
- Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I, Silvermann NH, Tajik AJ: Recommendations for quantification of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr 1989, 2: 358-367.View ArticlePubMedGoogle Scholar
- Weyman AE: Principles and practice of echocardiography. Chap 1. Philadelphia: Lea & Febiger 3-27.Google Scholar
- Porter TR, Xie F, Li S, Kricsfeld D, Deligonul U: Effect of transducer stand-off on the detection, spatial extent, and quantification of myocardial contrast defects caused by coronary stenosis. J Am Soc Echocardiogr 1999, 12: 951-956.View ArticlePubMedGoogle Scholar
- Angelsen BAJ: Principles of medical ultrasound imaging and measurements. In Ultrasound Imaging. Volume II. 1st edition. Trondheim: Emantec AS; 2000:1.3-1.99.Google Scholar
- Krams R, Sipkema P, Westerhof N: Coronary oscillatory flow amplitude is more affected by perfusion pressure than ventricular pressure. Am J Physiol 1990, 258: H1889-1898.PubMedGoogle Scholar
- Hiramatsu O, Kimura A, Yada T, Yamamoto T, Ogasawara Y, Goto M, Tsujioka K, Kajiya F: Phasic characteristics of arterial inflow and venous outflow of right ventricular myocardium in dogs. Am J Physiol 1992, 262: H1422-1427.PubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.